FIORINAL CAPSULE

국가: 캐나다

언어: 영어

출처: Health Canada

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
07-06-2023

유효 성분:

BUTALBITAL; CAFFEINE; ACETYLSALICYLIC ACID

제공처:

ARALEZ PHARMACEUTICALS CANADA INC

ATC 코드:

N02BA71

INN (International Name):

ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS

복용량:

50MG; 40MG; 330MG

약제 형태:

CAPSULE

구성:

BUTALBITAL 50MG; CAFFEINE 40MG; ACETYLSALICYLIC ACID 330MG

관리 경로:

ORAL

패키지 단위:

100

처방전 유형:

Schedule G (CDSA IV)

치료 영역:

BARBITURATES

제품 요약:

Active ingredient group (AIG) number: 0301241001; AHFS:

승인 상태:

APPROVED

승인 날짜:

2015-12-01

제품 특성 요약

                                PRODUCT INFORMATION
FIORINAL
®
(acetylsalicylic acid-caffeine-butalbital)
Capsules
USP
Combination Analgesic
Aralez Pharmaceuticals Canada Inc.*
DATE OF REVISION:
6733 Mississauga Rd., Suite 800
June 7, 2023
Mississauga, Ontario
L5N 6J5
www.miravohealthcare.com
Submission Control No: 270273
*Doing business as (d/b/a) Miravo Healthcare
_ _
_ _
_Page 2 of 22_
PRODUCT INFORMATION
NAME OF DRUG
FIORINAL
®
(acetylsalicylic acid-caffeine-butalbital)
USP
THERAPEUTIC CLASSIFICATION
Combination Analgesic
ACTION AND CLINICAL PHARMACOLOGY
Pharmacologically, FIORINAL
®
(ASA-caffeine-butalbital) combines the analgesic properties of
acetylsalicylic acid (ASA) with the anxiolytic and muscle relaxant
properties of butalbital.
PHARMACOKINETICS:
The behaviour of the individual components is described below.
_ACETYLSALICYLIC ACID (ASA) _
ASA
is
a
salicylate
that
binds
to
the
cyclooxygenase
enzyme
leading
to
a
reduction
in
prostaglandin activity. The systemic availability of ASA after an oral
dose is highly dependent
on the dosage form, the presence of food, the gastric emptying time,
gastric pH, antacids,
buffering agents, and particle size. These factors affect not
necessarily the extent of absorption of
total salicylates but more the stability of ASA prior to absorption.
During the absorption process and after absorption, ASA is mainly
hydrolyzed to salicylic acid
and distributed to all body tissues and fluids, including fetal
tissues, breast milk, and the central
nervous system (CNS). Highest concentrations are found in plasma,
liver, renal cortex, heart, and
lung. In plasma, about 50% - 80% of the salicylic acid and its
metabolites are loosely bound to
plasma proteins.
_ _
_ _
_Page 3 of 22_
The clearance of total salicylates is subject to saturable kinetics;
however, first-order elimination
kinetics are still a good approximation for doses up to 650 mg. The
plasma half-life for ASA is
about 12 minutes and for salicylic acid and/or total salicylates is
about 3 hours.
The elimination of therapeutic doses is through the kidneys
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

제품 특성 요약 제품 특성 요약 프랑스어 17-05-2018